Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC100041079 Inhibitors

The class of LOC100041079 inhibitors comprises synthetic molecules designed to interfere with specific enzymes and signaling molecules within cellular pathways. These compounds primarily target kinases, which are enzymes crucial for regulating a variety of cell functions, including growth and survival. By inhibiting these kinases, the compounds may indirectly affect the activity of LOC100041079. Some molecules within this class inhibit enzymes in the phosphoinositide 3-kinase (PI3K) family, impacting cell movement and growth. Other molecules focus on blocking the protein kinase Akt, which plays a role in metabolism, cell proliferation, and survival. There are also compounds that target specific members of the mitogen-activated protein kinase (MAPK) family, which includes enzymes that regulate cell differentiation and response to external stimuli.

A different set of inhibitors targets mTOR, a key regulator of cell growth that responds to environmental cues. By inhibiting mTOR, these molecules might impact LOC100041079's activity.Additionally, some inhibitors in this class are designed to block the action of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2), both of which are involved in controlling cell growth and survival.Lastly, multi-kinase inhibitors target various receptor tyrosine kinases (RTKs), which are implicated in cell signaling and proliferation. These inhibitors can affect multiple pathways and may alter the activity of LOC100041079 by this broad mechanism.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a steroidal metabolite of Penicillium funiculosum and acts as a potent phosphoinositide 3-kinase (PI3K) inhibitor, which may affect signaling pathways that LOC100041079 is involved in.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$104.00
$141.00
14
(1)

Triciribine is a synthetic tricyclic nucleoside that inhibits the activation of Akt, a serine/threonine kinase, potentially affecting downstream effects of LOC100041079.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a synthetic molecule functioning as a PI3K inhibitor, which may alter pathways interacting with LOC100041079.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin is a macrolide compound that inhibits mTOR, a key kinase that could be in the pathway where LOC100041079 functions.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an anthrapyrazolone inhibitor of c-Jun N-terminal kinase (JNK), affecting stress and inflammatory response pathways that might intersect with LOC100041079.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a pyridinyl imidazole that acts as a specific inhibitor of p38 MAP kinase, potentially altering signaling pathways involving LOC100041079.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is a synthetic compound functioning as a MEK inhibitor, which may have an impact on the mitogen-activated protein kinase (MAPK) pathway associated with LOC100041079.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Gefitinib is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, which may disrupt signaling pathways that LOC100041079 is a part of.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Erlotinib is another EGFR tyrosine kinase inhibitor, which might influence signaling networks where LOC100041079 is implicated.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Lapatinib is a dual tyrosine kinase inhibitor which targets both EGFR and HER2/neu, potentially modifying the function of pathways involving LOC100041079.